Santiago Ponce-Aix

6PUBLICATIONS
130CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2026
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Belén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre

|Sep 03, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.

Francesco Facchinetti, Yohann Loriot, Floriane Brayé

|Apr 17, 2024
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer.

Melina Peressini, Rosario Garcia-Campelo, Bartomeu Massuti

|Jun 28, 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer.

Francesco Facchinetti, Antoine Hollebecque, Floriane Braye

|Jun 26, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.

Naoual Menssouri, Loïc Poiraudeau, Carole Helissey

|Oct 15, 2020
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors.

Iván Márquez-Rodas, Federico Longo, Maria E Rodriguez-Ruiz

Pageof 1

Frequent Collaborators

3 joint publications

Stefan Michiels

3 joint publications

Jean-Yves Scoazec

3 joint publications

Yohann Loriot

3 joint publications

Lambros Tselikas